Free Access
Med Sci (Paris)
Volume 23, Number 5, Mai 2007
Page(s) 526 - 532
Section M/S revues
Published online 15 May 2007
  1. Winkelsteinw JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79 : 155–69. [Google Scholar]
  2. Guichard C, Pedruzzi E, Fay M, et al. The Nox/Duox family of ROS-generating NADPHoxidases. Med Sci (Paris) 2006; 22 : 953–9. [Google Scholar]
  3. Berthier S, Paclet MH, Lerouge S, et al. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J Biol Chem 2003; 278 : 25499–508. [Google Scholar]
  4. Reeves EP, Lortat Jacobs HL, Messina CGM, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416 : 291–7. [Google Scholar]
  5. Wallach TM, Segal AW. Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J 1997; 321 : 583–5. [Google Scholar]
  6. Segal AW, West I, Wientjes F, et al. Cytochrome b245 is a flavocytochrome containing FAD and NADPH-binding site of the microbicidal oxidase of phagocytes Biochem J 1992; 284 : 781–8. [Google Scholar]
  7. Henderson LM, Thomas S, Banting G, Chappell JB. The arachidonate-activatable, NADPH oxidase-associated H+ channel is contained within the multi-membrane-spanning N-terminal region of gp91-phox. Biochem J 1997; 325 : 701–5. [Google Scholar]
  8. DeCoursey TE, Cherny VV, Morgan D, Katz BZ, Dinauer MC. The gp91phox component of NADPH oxidase is not the voltage-gated proton channel in phagocytes, but it helps. J Biol Chem 2001; 276 : 36063–6. [Google Scholar]
  9. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79 : 170–200. [Google Scholar]
  10. Roos D, De Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87 : 1663–81. [Google Scholar]
  11. Stasia MJ, Bordigoni P, Floret D, et al. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet 2005; 116 : 72–82. [Google Scholar]
  12. Stasia MJ, Brion JP, Boutonnat J, Morel F. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB. J Infect Dis 2003; 188 : 1593–604. [Google Scholar]
  13. Heyworth PG, Curnutte JT, Rae J, et al. Hematologically important mutations: X-linked chronic granulomatous disease (second update). Blood Cells Mol Dis 2001; 27 : 16–26. [Google Scholar]
  14. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003; 15 : 578–84. [Google Scholar]
  15. Cross AR, Heyworth PG, Rae J, Curnutte JT. A variant X-linked chronic granulomatous disease patient (X91+) with partially functional cytochrome b. J Biol Chem 1995; 270 : 8194–8200. [Google Scholar]
  16. Stasia MJ, Lardy B, Maturana A, et al. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail. Biochem Biophys Acta 2002; 1586 : 316–30. [Google Scholar]
  17. Leusen JH, de Boer M, Bolscher BG, et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest 1994; 93 : 2120–6. [Google Scholar]
  18. Leusen JH, Meischl C, Eppink MH, et al. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase : consequences for oxidase assembly. Blood 2000; 95 : 666–73. [Google Scholar]
  19. Dinauer MC, Curnutte JT, Rosen H, Orkin SH. A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J Clin Invest 1989; 84 : 2012–6. [Google Scholar]
  20. Tucker KA, Lilly MB, Heck L, Rado TA. Characterization of a new human diploid myeloid leukaemia cell line (PLB-985). Blood 1987; 70 : 372–8. [Google Scholar]
  21. Zhen L, King AA, Xiao Y, et al. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc Natl Acad Sci USA 1993; 90 : 9832–6. [Google Scholar]
  22. Schapiro BL, Newburger PE, Klempner MS, Dinauer MC. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med 1991; 325 : 1786–90. [Google Scholar]
  23. Yu L, Cross AR, Zhen L, Dinauer MC. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant. Blood 1999; 94 : 2497–504. [Google Scholar]
  24. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4 : 181–9. [Google Scholar]
  25. Taylor WR, Jones DT, Segal AW. A structural model for the nucleotide binding domains of the flavocytochrome b-245 beta-chain. Protein Sci 1993; 2 : 1675–85. [Google Scholar]
  26. Li, XJ, Grunwald D, Mathieu J, Morel F, Stasia MJ. Crucial role of two potential cytosolic regions of Nox2, 191TSSTKTIRRS200 and 484DESQANHFAVHHDEEKD500, on NADPH oxidase activation. J Biol Chem 2005; 280 : 14962–73. [Google Scholar]
  27. Li XJ, Fieschi F, Paclet MH, et al. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 2007; 81 : 238–49. [Google Scholar]
  28. Shatwell KP, Dancis A, Cross AR, Klausner RD, Segal AW. The FRE1 ferric reductase of Saccharomyces cerevisiae is a cytochrome b similar to that of NADPH oxidase. J Biol Chem 1996; 271 : 14240–4. [Google Scholar]
  29. Karplus PA, Daniels MJ, Herriott JR. Atomic structure of ferredoxin-NADP+ reductase : prototype for a structurally novel flavoenzyme family. Science 1991; 251 : 60–6. [Google Scholar]
  30. Bionda C, Li XJ, van Bruggen R, et al. Functional analysis of a two-amino acid substitution in gp91phox in a patient with X-linked flavocytochrome-b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 2004; 115 : 418–27. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.